Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Journal of Personalized Medicine
|
June 2, 2021
CFTR Modulators: Does One Dose Fit All?
Renske van der Meer, Erik B Wilms, Harry G M Heijerman
Current Opinion in Pulmonary Medicine
|
September 11, 2019
Prevention of drug-related complications in cystic fibrosis
Renske van der Meer, Daan J Touw, Harry G M Heijerman
Current Opinion in Pulmonary Medicine
|
October 10, 2017
The optimal approach to nutrition and cystic fibrosis: latest evidence and recommendations
Francis M Hollander, Nicole M de Roos, Harry G M Heijerman
Journal of Personalized Medicine
|
August 27, 2021
Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators
Bente L Aalbers, Inez Bronsveld, Regina W Hofland, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 19, 2021
Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controls
Renske van der Meer, Erik B Wilms, Richart Sturm, et al.
Acta Oto-Laryngologica
|
July 9, 2008
Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients
Renske J Scheenstra, Evert Rijntjes, Dénes L J Tavy, et al.
Acta Oto-Laryngologica
|
May 30, 2009
No hearing loss after repeated courses of tobramycin in cystic fibrosis patients
Renske J Scheenstra, Harry G M Heijerman, Charlotte L Zuur, et al.
Pediatric Pulmonology
|
June 12, 2012
Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects
Erik B Wilms, Daniel J Touw, Harry G M Heijerman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 31, 2019
Aligning patients' needs and research priorities towards a comprehensive CF research program
Jacquelien J Noordhoek, Vincent A M Gulmans, Harry G M Heijerman, et al.
Clinics (Sao Paulo, Brazil)
|
August 19, 2023
The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort
Lisa M Oppelaar, Bart Luijk, Harry G M Heijerman, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Journal of Personalized Medicine
|
June 2, 2021
CFTR Modulators: Does One Dose Fit All?
Renske van der Meer, Erik B Wilms, Harry G M Heijerman
Current Opinion in Pulmonary Medicine
|
September 11, 2019
Prevention of drug-related complications in cystic fibrosis
Renske van der Meer, Daan J Touw, Harry G M Heijerman
Current Opinion in Pulmonary Medicine
|
October 10, 2017
The optimal approach to nutrition and cystic fibrosis: latest evidence and recommendations
Francis M Hollander, Nicole M de Roos, Harry G M Heijerman
Journal of Personalized Medicine
|
August 27, 2021
Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators
Bente L Aalbers, Inez Bronsveld, Regina W Hofland, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
May 19, 2021
Pharmacokinetic interactions between ivacaftor and cytochrome P450 3A4 inhibitors in people with cystic fibrosis and healthy controls
Renske van der Meer, Erik B Wilms, Richart Sturm, et al.
Acta Oto-Laryngologica
|
July 9, 2008
Vestibulotoxicity as a consequence of systemically administered tobramycin in cystic fibrosis patients
Renske J Scheenstra, Evert Rijntjes, Dénes L J Tavy, et al.
Acta Oto-Laryngologica
|
May 30, 2009
No hearing loss after repeated courses of tobramycin in cystic fibrosis patients
Renske J Scheenstra, Harry G M Heijerman, Charlotte L Zuur, et al.
Pediatric Pulmonology
|
June 12, 2012
Azithromycin maintenance therapy in patients with cystic fibrosis: a dose advice based on a review of pharmacokinetics, efficacy, and side effects
Erik B Wilms, Daniel J Touw, Harry G M Heijerman, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
March 31, 2019
Aligning patients' needs and research priorities towards a comprehensive CF research program
Jacquelien J Noordhoek, Vincent A M Gulmans, Harry G M Heijerman, et al.
Clinics (Sao Paulo, Brazil)
|
August 19, 2023
The prevalence of vascular and metabolic complications after lung transplant in people with cystic fibrosis in a Dutch cohort
Lisa M Oppelaar, Bart Luijk, Harry G M Heijerman, et al.
Page
of 5